Open Access Research Article
CORPORATE SOCIAL RESPONSIBILITY IN INDIAN PHARMA: COMPLIANCE WITH THE COMPANIES ACT, 2013.
Published Paper
Article Details
CORPORATE SOCIAL
RESPONSIBILITY IN INDIAN PHARMA: COMPLIANCE WITH THE COMPANIES ACT, 2013.
AUTHORED BY - ANANYA SHARMA & GITARTHI CHANDRA
ABSTRACT
This paper
study the compliance of the Indian pharmaceutical sector with the CSR
obligations under the Companies Act 2013. The section 135 of the Companies Act,
2013 gives mandate to a seen corporation to make contribution towards corporate
social responsibility(CSR). Implementation troubles are amounts dedication and
lack of growth or effectiveness measurement, as well as stakeholder
involvement. CSR activities and efforts give enough room for a brand to a level
where a positive competition would be in an inertia. It is uncertain whether it
could dilute technological progress given extra safeguarding of IP rights and
may also protect companies that are credible in this area from others that
could be left behind. While trends are the flashy things (like anti-corruption
or environmental sustainability), trends are usually rather stagnant and mostly
address old corporate social responsibility issues, diversity, equity and
technology use. The pharmaceutical sector, which constitute one of the main
pillars of health, is required to take
on a more advanced role in CSR. The research paper examines the extent to which
the law regulating CSR, the extent to which its enforcement in the
pharmaceutical sector works, and the influence of such endeavours on the social
well-being. Although the priority and application CSR practices are getting a
new thrust, the differences in the implementation of these practices are
growing due to various factors such as size, governance structure and market
conditions. Assuring the compliance is not merely one goal of CSR. Firstly, the
tool is the vehicle of social transformation and payment of holistic issues
like wage disparity, life poverty and environmental destruction. Finally, the
enterprise having CSR leads to social license in the community, collaborative
business models based on ethical standpoints of social responsibilities, and
best of all, a respectable participation to the 17 Sustainable Development
Goals on India. The discourse is rounded up by the recommendations to
strengthen CSR performance and accountability in the Indian pharmaceutical
industry, and the determination of new directions for research.
KEYWORDS –
Corporate Social
Responsibility, Companies Act 2013, Sustainable Development Goals and
Pharmaceutical sector.
INTRODUCTION-
Guiding the
corporate governance and business strategy through the Corporate Social
Responsibility (CSR) is an important aspect, especially from the Companies Act
Section 135[1],
in India. The pharmaceutical industry, being intrinsically linked to the health
and well-being of the populace, is at the forefront of this socio-economic
interface. Carrying out sustainability and socio-economic inclusive development,
the section[2]
enforced these certain businesses to improve their profits into CSR activities.
Accepting this rule, organizations must make up the CSR Committee, the CSR
policy and support the performed activities to build a social welfare, environment
sustainability and living an intact community life. Given the critical role
that this industry plays in healthcare, the expectations from pharmaceutical
companies regarding CSR are uniquely demanding. Challenges on CSR
implementations alongside the legal obligations under Section 135[3]
are also present in the corporate terrain of India. From the other side,
enterprises face certain difficulties in determining priorities of CSR. On the
flip side, however, there are many positive aspects of CSR, like the one of the
strengthening of the brands reputation, the management of the relationships
with the stakeholders and of the competitive advantage. The organizations can
stay ahead of the competitors and allure applicants and workers by CSR’s means
which in turn act can to prevent the risks such as violation of regulations as
well as harming the organization's image. The Act's[4]
CSR provisions, encapsulated primarily in Section 135[5],
along with the Companies (Corporate Social Responsibility Policy) Rules, 2014[6],
are pioneering steps in integrating CSR into the corporate governance
framework. this paper will analyse the extent to which Indian pharmaceutical
companies adhere to these statutory CSR obligations. Furthermore, it will
consider the accountability mechanisms that are in place and how these are
enforced by regulatory authorities to ensure compliance.
RESEARCH
QUESTIONS –
1.
How is Corporate Social Responsibility (CSR) implemented
by Indian companies?
2.
How different dimensions of CSR are prioritised such
as environmental responsibility, ethical responsibility, philanthropic
responsibility, and financial responsibility?
3.
How do Pharmaceutical companies in India implement
CSR?
4.
How do pharmaceutical companies in India comply with
the provisions of CSR provisions outlines in Companies Act, 2013[7]?
5.
What are the difficulties faced by pharmaceutical companies
faced up to this very moment in CSR?
RESEARCH OBJECTIVES –
1.
To evaluate how CSR is implemented in India.
2.
To evaluate how Indian businesses view several aspects
of corporate social responsibility (CSR), including as financial, ethical,
charitable, and environmental responsibility, and what their top objectives are
in this regard.
3.
To analyse how Indian pharmaceutical sector implements
CSR.
4.
To assess how legal frameworks, including the Companies
Act of 2013[8], affect Indian pharmaceutical
sector’s compliance and CSR policies, and to consider the consequences for
accountability and corporate governance.
5.
To list and evaluate the obstacles that Indian pharmaceutical
sector faces while putting CSR regulations into practice, with an emphasis on
resource distribution, stakeholder involvement, effect assessment, and legal
compliance.
METHODOLOGY-
The
methodology for researching CSR under the Companies Act, 2013[9]
involves a comprehensive literature review of relevant legal provisions,
scholarly articles, and case studies. This is followed by qualitative and
quantitative analysis of CSR practices and compliance among Indian companies
and financial data analysis. The research paper also aims to explore the impact
of CSR on corporate governance, sustainability, and stakeholder relations. The
findings of the research paper can be utilised by academicians, stakeholders,
companies and so on.
LITERATURE
REVIEW-
1.
(Dahlsrud,
2008; Carroll, 1991)[10]
in their study defined CSR as a ‘self-policing business”. CSR activities by a
company promotes social responsibility among the stakeholders, and the society.
They also wrote on types of CSR activities, such as environmental protection, financial
investments in sustainable development, ethical behaviour and philanthropic
giving.
2.
Section 135 of the corporations Act, 2013, which
requires corporations beyond a specific level to spend at least 2% of their
average net earnings on CSR initiatives, is the main legal framework
controlling CSR in India, as highlighted in the literature (Bhandari & Abe,
2021)[11].
It also covers the laws and guidelines pertaining to the definition of
permissible CSR activities, the computation of CSR expenses, and the necessity
of reporting (Batra, 2019)[12].
3.
The book recognises that putting CSR mandates into
practice can be difficult for businesses for a variety of reasons, including
finding appropriate initiatives, gauging impact, engaging stakeholders, coordinating
CSR with corporate goals, and adhering to changing legal requirements (Chopra
&Marriya, 2018[13];
Jain & Vashisht, 2017[14]).
4.
Before the Companies Act, 2013 was
enacted, prominent Indian pharmaceutical businesses' CSR policies were
investigated in a research by Sharma and Khanna[15]. They discovered that
although some businesses were aggressively pursuing CSR projects, there was a
dearth of regularity and a methodical methodology. Their study recommended that
there should be a transparency with a company’s CSR policy.
5.
Mishra and Suar[16] investigated the reasons
for CSR programs in the Indian pharmaceutical sector in a different research. In
their study they propounded that with CSR activities businesses gain brand
enhancement and it also results in staff retention. To make their business a
success, the authors opined that CSR activities should be coordinated with main
business functions.
6.
Bhatia and Tuli[17] in their work researched
on CSR and the success of Indian pharmaceutical companies. In their work they
concluded that the businesses which were more socially conscious and were
transparent about their CSR activities were more likely to gain financial
success.
ANALYSIS
Corporate
Social Responsibility-
"Corporate
social responsibility" (CSR), a self-policing business idea, helps an
organisation be held socially responsible by the public, its stakeholders, and
itself. Businesses that practise corporate social responsibility are aware of
how their actions affect society's social, economic, and environmental
dimensions. When a company engages in corporate social responsibility (CSR), it
benefits the environment and society rather than detracting from them. CRS
initiatives are designed to address global issues.
CSR
can generally be divided into four types, namely-
1.
Environmental responsibility: The
foundation of corporate social responsibility is environmental protection. By
reducing industrial pollutants and emissions, recycling trash, replenishing
natural resources like trees, or creating CSR-compliant product lines, a
corporation may demonstrate environmental stewardship.
2.
Ethical
accountability: Corporate social responsibility includes acting in a fair and
morally upright manner. A few instances of ethical responsibility in action
include treating all customers fairly, regardless of their age, ethnicity,
culture, or sexual orientation; offering competitive pay and benefits to
employees; using vendors across demographics; making full disclosures; and
being transparent with investors.
3.
Philanthropic responsibility: Businesses
and companies have to return to the community as per CSR mandates. It can be
done in many ways, such as donations to charities, supporting fundraisers,
supporting employee-led charitable endeavours and so on.
4.
Financial responsibility: An
enterprise can set goals on the line of corporate social responsibility (CSR),
ethical and environmental responsibility, management and product development,
but these plans will need money, obtaining grants, running programmes or
offering a new product. These inclusive activities can be seen in
recruiting people from different backgrounds, creating long lasting,
sustainable goods, raising social consciousness, as well as community
engagement for environmental projects.
A
study that was published in the Journal of Consumer Psychology[18] indicates that customers
are more inclined to behave favourably toward a business that has taken steps
to meet their needs.Using CSR tactics can help businesses beat the market by
enhancing investors' perceptions of their worth. According to research by the
Boston Consulting Group, businesses regarded as leaders in governance, social,
or environmental issues were valued 11% higher than their rivals[19].
CSR
in India-
Section
135 of the Companies Act of 2013[20] covers CSR. Companies
covered by section 135(1) of the Companies Act, 2013[21] are required to implement
a CSR program and spend 2% of their net earnings over the next three years. A
corporation registered under Section 8 of the Companies Act, 2013[22] for philanthropic
purposes is subject to the CSR requirements.
The
Companies (CSR Policy) Rules, 2014, define CSR in Rule 2(1)(d)[23], which also prohibits the
following acts from qualifying as CSR activities:
·
Activities carried out in the company's
regular course of business.
·
Activities carried out outside of India,
with the exception of training
·
Indian athletes who represent any state or
union nationally or internationally
·
Contribution to any political party under
Section 182 of the Act, whether direct or indirect, in whatever amount.
·
Activities that benefit the company's
personnel marketing benefits from sponsorship initiatives for goods and
services.
·
Actions taken to carry out mandatory
requirements under any applicable Indian legislation.
In
order to calculate the amount spent on CSR activities, the average net profit
must be calculated in accordance with Section 198 of the Act[24], except the items listed
in Rule 2(1)(h) of the Companies (CSR Policy) Rules, 2014[25]. A company's net profit
must be calculated with a few additions, deletions, or changes according to
Section 198[26]
of the Act. It mostly leaves out income tax, capital payments and receipts, and
set-offs for prior losses.
If
the requirements outlined in Rule 7(3) of the Companies (CSR Policy) Rules,
2014[27] are met, the excess CSR
spending may be deducted from the necessary 2% CSR expenditure for the next
three fiscal years. The term "surplus" refers to money obtained from
the expenditure of funds on CSR activities. This includes revenue from CSR
projects, interest gained by the implementing agency on funds supplied under
CSR, disposal or sale of project-related goods, and other revenue streams of a
similar kind.
The
excess coming out of CSR efforts should be employed strictly for CSR
objectives. Section 135(5)[28] of the Act specifies that
the corporation shall give precedence to local regions surrounding where it
works. But with the introduction of IT and the rise of modern organizations
such as aggregators, e-commerce, and process-outsourcing firms, it is now
challenging to identify the local region for different kinds of operations. As
a result, the Act's preference for the local region is just advisory and not
required, and businesses must weigh local area preference against national
interests.
India's
corporate social responsibilitylandscape has changed dramatically in the last
several years as businesses have increased their CSR initiatives and the
government has passed new laws to support CSR. A few recent advancements in CSR
in India:
·
Digitalization of Corporate Social
Responsibility: For enterprises to register and report on their CSR
initiatives, the government has developed an online platform. Companies may now
more easily track and manage their CSR spending through the platform and
present their activities to stakeholders.
·
The addition of COVID-19 alleviation
actions to CSR: A circular from the Ministry of Corporate Affairs in 2020 said
that businesses might implement COVID-19 relief efforts, such building
hospitals, offering healthcare services, or making contributions to the PM's
Citizen Assistance and Relief in Emergency Situations (PM Cares Fund).
·
Introducing the National Voluntary
Guidelines (NVGs) on Business Responsibilities in Social, Environmental, and
Economic Aspects: The Ministry of Corporate Affairs unveiled the NVGs in 2011,
offering businesses direction on how to incorporate CSR into their day-to-day
operations.
·
Emphasis on Education: In India, CSR
activities have placed a strong emphasis on education. Companies have promoted
activities like training of the teachers, building schools and providing
scholarships.
·
Partnership with Non-Profits: Companies
are working more and more with charitable institutions to carry out their CSR
programs. This has made it easier for companies to take advantage of NGOs'
experience and knowledge in specific fields of social development.
·
The promotion of social entrepreneurship: The
Ministry of Corporate Affairs introduced
the CSR Rules in 2013, which allow the companies to support entrepreneurship
endeavours. The purpose of this provision is to encourage innovation and
entrepreneurship in the social sector.
·
The emphasis on impact assessment: Since
the CSR Rules allowed companies to evaluate the effects of their CSR efforts,
impact assessments have become more important. Previously, companies were
allowed to do so up to 5% of their CSR expenditure.
The
Companies (Corporate Social Responsibility Policy) Amendment Rules 2022[29] set a cap of Rs. 50
lakhs, or 2% of total CSR spending, on the cost of social impact evaluations,
which are categorized as CSR spending.
Landmark
Case laws-
M.C.
Mehta vs. Union of India[30]: This case resolved the
principle of 'absolute liability' for the harm caused by industries that act in
the hazardous activities. The case law made it clear that businesses cannot
harm the environment and the community for their profits.
Vellore
Citizens Welfare Forum vs. Union of India:[31] In this plea, the highest
court of the country understood the concept of 'Sustainable Development' and
'Precautionary Principle' along with being accepted as part of the
environmental law of the country. Such follow-up affects the CSR and cannot
allow companies to ignore the harm to sustainability done through their
activities.
Union
Carbide Corporation vs. Union of India[32]: The lesson of the Bhopal
Gas Tragedy case not only revealed corporate neglect but also led to a fine
amount which was meant for the Bhopal Relief Gas Fund.
Tata
Motors Ltd. vs.Antonio Paulo Vaz&Anr.[33]: Tata Nano Plant in
Singur region, West Bengal, as another example, marked the need for the
judiciary to strike a balance between industrialization and the claim of local
communities. Trierweiler herself practically became a symbol of the Breton
people of every class as well as of farmers who felt they became easy prey of
big companies.
Union
of India & Ors. v. Novartis AG[34]: This landmark case law
is important in healthcare area, namely the access of patients to healthcare
and also, patent law. The beta crystalline form of Imatinib Mesylate, a
medication used to treat chronic myeloid leukaemia, was not granted a patent by
Novartis AG, according to the Supreme Court of India. The Indian Patents Act's
Section 3(d) was interpreted by the court in order to support its ruling, which
attempts to guarantee that only true advances are patented and to prevent
patents from being evergreened. Apart from focusing on patent law, it also
states that life-saving medicines have to be made affordable and accessible for
all as a part of corporate social responsibility.
Union of India v. Bayer Corporation[35]: The Indian Patent Controller's decision to provide Natco Pharma a compulsory license to produce a generic version of Bayer's medicine Sorafenib Tosylate, which is used to treat liver and kidney cancer, was maintained by the Bombay High Court in this case. The medicine was not properly supplied in the Indian market and was not accessible at a reasonable price, which is why the obligatory license was given. The case law said that judiciary and government play an important role in ensuring the availability of life saving medicines.
Pfizer
Inc. v. Union of India[36]: The Delhi High Court
heard this matter over Pfizer's patent for its pneumonia vaccine, PCV13
(Prevenar 13), being revoked due to non-working reasons. The court
ruled that the government would have to conclude the examination of the patency
procedure considering the efficacy and fair price of the vaccine for the
patient reverse agenda. The consequences of the court ruling cover many
areas such as pharmaceutical companies duties to ensure that the patented
products are serving the public and there is should be the application should
be for the common prosperity and CSR purposes, and the the case was more about
patent law than CSR.
Compliance
with CSR in India-
Fulfilling
corporate social responsibility obligations presents a number of challenges.
Firstly, choosing the right projects that complement an organization's core
values and business goals can be difficult. Secondly, companies must measure
and report the impact of their CSR initiatives, which calls for an effective
monitoring and evaluation system. Lastly, companies must make sure their CSR
efforts are sustainable and have a long-lasting effect on the communities they
serve. The promotion of CSR compliance is aided by the government and other
stakeholders. To track and keep an eye on the CSR initiatives that businesses
are involved in, the Ministry of Corporate Affairs has established a CSR site.
Additionally, the platform offers organizations information and advice to
assist them meet the CSR standards.
Promoting
CSR compliance also involves other important players, including rating
agencies, industry groups, and civil society organizations. Companies can
receive advice from civil society organizations on what initiatives best suit
the requirements of the communities they serve. Companies are incentivized to
comply with CSR regulations by rating organizations, which assess and rank
businesses according to their CSR performance.
In India, certain corporations are required to
comply with CSR regulations, and fulfilling these commitments might provide
difficulties. Nonetheless, the government and other stakeholders are crucial in
encouraging CSR compliance and offering businesses tools and advice to assist them
fulfil their obligations. In India, certain corporations are required to
comply with CSR regulations, and fulfilling these commitments might provide
difficulties. Nonetheless, the government and other stakeholders are crucial in
encouraging CSR compliance and offering businesses tools and advice to assist
them.
The
corporation and its directors may face fines and legal action for failing to
comply with CSR obligations. Stakeholders may obtain information on CSR
initiatives using the platform, which also lets businesses post their CSR
reports. Also, the MCA has published rules and circulars on CSR reporting to ensure
all the companies follow the requirements.
Generally,
there have been cases of non-compliance even though regulatory measures are in
place in India to ensure CSR compliance. Enforcing CSR duties and keeping firms
responsible for their CSR actions are crucial tasks performed by stakeholders
including investors, rating agencies, and civil society groups.
In
India, CSR is now seeing a number of developments. The growing emphasis on
environmental responsibility and sustainability is one trend. Businesses are
acting to promote renewable energy, preserve natural resources, and lessen
their carbon impact. The focus on education and skill development is another
trend. Businesses are funding training and education initiatives to help young
people become more employable and to encourage skill development in rural
regions.
Still,
there are prospects for CSR in India in the future. The possibility of
cooperation between businesses, civil society groups, and the government is one
opportunity. Cooperation may improve the effect of CSR initiatives by sharing
knowledge and leveraging resources. The potential for CSR to spur innovation
and competitiveness presents another chance. Businesses that are dedicated with
CSR, businesses may stand out from the competition and draw in clients and
investors that respect environmental and social responsibility.
How
do Pharmaceutical Companies in India implement CSR?
In
recent times, the Corporate Social Responsibility (CSR), that is, the
responsibility of the private sector to take care of the people and the
surrounding environment has become a very important aspect of business
operations globally, such as the pharmaceutical industry of India. Shift
towards clean economic management and considerations of sustainability has
prompted Indian pharmaceutical companies to incorporate CSR into their
company's beliefs. This integration is stricter than just avoiding taxes and
avoiding regulations.
Similarly environmental sustainability
being their main CSR initiative in India pharmaceutical companies are also
focusing on it as well. They understand that they must take actions to reduce
their carbon footprint as well as maintain a balance between their involvements
and the natural environment. Through their implementation of sustainable
technologies these organizations are also an indication that they care about
the environment and for the long-term targets of sustainability.
Moreover,
indeed, the Indian pharmaceutical industry is not strangers to the community
development projects which aims at improvement of standard of living as well as
empowering the poor and the weak. Such companies not only increase economic
emancipation but also ascribe social inclusion that leads to elevation of these
communities thus bringing a positive change to the society in general.
Along
with these, business ethics, governance, and ethics in the implementation of
CSR for pharma companies in India are the crucial issues. They abide by the
high level of ethics in research, manufacturing and marketing to prevent the
products problems such as the absence of safety, efficacy, and quality of the
products. These have transparency, honesty, and accountability as the core of
their operation which therefore includes their interaction with medical staff,
regulatory bodies, and to the general public.
Indian
pharmaceutical companies subscribe to the CSR as one of the fundamental aspects
of their philosophy and they have a greater purpose than just to earn money by
making people better. Access to healthcare, education, environment
sustainability, and community development are an initiative area to all
stakeholders. Companies with healthy future for all stakeholders have these in
mind. The CSR inclusion into their corporate strategies in India,
pharmaceutical companies aren’t only responsibilities as societies, but rather
at that point, trust with the stakeholders is built, repour is strengthened,
and the success of the business can be driven on long term basis.
How
do pharmaceutical companies in India comply with the provisions of CSR
provisions outlines in Companies Act, 2013?
The
Companies Act, 2013[37],
which is applicable to India, introduced actually good regulations that CSR
stands for Corporate Social Responsibility. As stated in the Act, the companies
should designate a certain amount of their money for CSR activities. The
pharmaceutical companies in India, having to fulfil these provisions, are now
adjusting their CSR strategies to the outlined requirements in the Act while
balancing this with their business objectives and the social demands the
society presents.
To
start with, the pharmaceutical companies in India has an obligation to ensure
that the Companies Act, 2013[38]
is followed up by setting standard CSR committees made up of board members who
carry out the duties of formulating and implementing the CSR policies and
initiatives. They define the CSR development, set CSR expense targets,
supervise CSR project progress and impact. However, when these entities
incorporate the Act’s regulatory requirements on CSR in their organizational
ethos, they begin to reflect their unwavering adherence to the ethic of CSR
which is governed on the principle of correctness and accountability.
The
Indian pharmaceutical industry also followed a holistic approach for the
overall strategic planning and execution of their CSR objectives with
prescription issues as one of the primary focus areas being laid down under
Schedule VII of Companies Act, 2013[39].
In these main focus areas, healthcare is one of the focal needs that need to be
promoted, and together with elimination of hunger and poverty, these two
factors have been observed to be reasons for many diseases and disease-related
deaths. Thus, pharmaceutical companies tackle social problems and contribute to
the socio-economic development of the country, chosen wisely, according to
focus areas by selecting CSR projects that satisfy specified purposes.
In
the next, Indian drug manufacturers take very strict supervision and record
their CSR activity and capital cost as requested in the requirement of the
Companies Act, 2013[40].
They engage in precise CSR records keeping covering projects, the amounts spent
and the outcomes which should be disclosed in the company annual CSR reports
following the enclosures offered by the authorities.
Apart
from compliance with legislative regulations, the pharmaceutical companies in
India take part in stakeholders' engagement, which includes government bodies,
non-profit establishments, charity groups, local residents, and business mates
in co-ordination to take up CSR initiatives and allocate resources better for
optimum effect. Via different strategic partnerships and collaborations, these
companies are raising the extent and impact of their CSR programs and hence
establishing sustainable impacts and reciprocal benefits for the beneficiaries.
Additionally,
pharmaceutical firms in India incorporate CSR awareness into their strategic
procedures and business operation frameworks, so CSR values are instilled in
the organizational culture and core values. They put emphasis on ethical
behaviours, environmental sustainability, and social responsibility that span
the chain of values that starts right from the research and development to the
marketing and supply and demand chain. Spurring CSR as part of the core business
function, corporations clearly underpin that their aim is in the integrated
development and beneficial citizenship of responsible companies. Digital
platforms, data analytics, and other advanced tools are leveraged during CSR
project management to which emergent data and progress can be captured in
real-time and impact during and after the CSR initiatives can be measured.
Through embracing CSR innovation in this aspect, these organizations will
enhance also efficacy, scalability, and sustainability and, in the process,
socialization will be much facilitated to a great extent.
Indian
pharmaceutical companies have been in compliance with the Companies Act, 2013[41]
by forming CSR committees, aligning the CSR activities with statutory purposes
as well as focus areas, implementing efficient reporting mechanisms, engaging
with stakeholders, integrating CSR activities into business functions, and
capitalizing on innovation. Abiding with the regulation standards and
highlighting actions on ethical practices and social responsibility allows such
companies to be at the forefront of attaining sustainability advancements and
achieving the sustainable development goals, therefore making the true citizens
of the corporate responsibility.
CHALLENGES
AND OPPORTUNITIES
Identification of challenges in implementing CSR
mandates –
The
amendments of the Companies Act 2013[42], resulting
in the mandative provision of the CSR, act as an avenue for multiple problems
and opportunities for companies who are looking to find a balance in both
profit-driven and societal oriented objectives. Another area which is
challenging is securing and making stakeholders like employees, local people as
well as others who are relevant engaged, and if this is not so, it can
frustrate the success and sustainability of CSR efforts Alongside this,
harmonizing the CSR tasks with the company’s main business objectives proves to
be a complex quest for multiple firms. Ensuring that the company’s core
business is responsible for CSR without and interference and at the same time
remaining profitable requires strategic orientation which will take into
account economic, social and political issues of the society. Lastly,
compliance and reporting difficulties set forth by regulatory authorities
constitute long-term challenges, as sometime businesses have problems to suit
and adjust to evolving rules while they could potentially intimidate companies
and be risky for their reputation.
CSR
initiatives avail assimilation and expansion of scope through innovation.
These
challenges can turn into opportunities and bring new development in innovation
which can help the society at large. Through CSR, companies can improve their
image and reinforce consumer confidence by attracting the type of customers
that is becoming more conscious and selective regarding their choice of goods
and services that shown care for ethical approaches and the well-being of the
society. CSR activities aside from defending brand equity, act as risk
mitigation mechanisms as well. They protect business from either reputational
risk or regulatory scrutiny which secures long term survival of the enterprise.
The CSR also creates an avenue into markets that are emerging as well as
investment opportunities especially in those regions where consumer’s preference
and relative focuses on issues of sustainability and ecosystem protection are
key factors in the business and regulatory steers. Through CSR impetus,
business entities have the potential to harness creativity and cooperation in
shaping a new era where the enterprise both recognizes and attends to the
paramount societal issues and at the same time benefits the necessary
stakeholders.
Controlling
and procedure inferences for enhancing CSR compliance
CSR
compliance can be ensured along with the culture of socially responsible
companies by the use of policies and laws which are critical to make potential
playing field for corporate participation in CSR. Alongside this, tax
incentives, grants or subsidies could be used to motivate enterprises toward investing
in socially responsible activities which would encourage these companies to
engage in allowing public benefit beyond the mere mandatory obligations. And
providing services and programs which occupy management to the tip of CSR rules
and strategies is vital. With allocating funds towards education and training
programs for regulatory bodies, companies will be better guided to include CSR
in their mainstream business activities chiming in the betterment they are
doing. So, enforcement mechanisms and monitoring systems must be strengthened
for compliance with CSR regulations, deterrence of non-compliance, and
increases the risk of errant companies doing an egregious thing.
What
challenges do pharmaceutical companies face in implementing CSR? –
As pharmaceutical
companies do CSR projects, the complex nature of the industry, regulatory
barricades, stakeholder expectations, resource limitation, and the
socioeconomic landscape environment can’t be ignored.
One
important challenge for the pharmaceuticals in implementing CSR is whether they
will remain as small business or become large corporation which is depend on
society welfare as well as commercial interests. This is the reason why those
companies are operating in the healthcare sector in the first place: to make a
product and sell it on the market with an aim to make a profit and the business
grows. Integrating CSR into their operations definitely demand the allocation
of financial, manpower and time resources to serve the social and environmental
projects. In doing so the attention and the resources could be diverted from
the core business activities. However, achieving simultaneous profit
maximization and social & environmental impact while ensuring survival
through sustainability remains the industry leader’s predicament.
In
addition, the governing environment in the India poses some impediment for
pharmaceutical companies in the conduction of CSR. According to the Companies
Act, 2013 certain companies are required to allocate a portion of the profit to
the CSR expenditure however, there is no clarity on guidelines and reporting
procedures, instead there is only room for interpretation of this matter. This
grey area in compliance can result in confusing and inefficient CSR management
being put into place, obstructing business capabilities to fit its CSR
strategies properly.
Moreover,
pharmaceutical industry is faced with harms of secondary nature of stakeholder
involvement and management. Presenting divergent participants comprising of
local communities, government organs, non-governmental organizations,
healthcare professionals, and consumers involves good communication,
collaboration, and laying a good relationship for social cohesion. Ensuring the
reconciliation conflicting interests of stakeholders, addressing the
expectations of stakeholders, and executing transparent and inclusive
decision-making procedures are a few of the complex challenges of managing
companies in a fluctuation and fast economy
The
resource constraints are another big challenge which pharmaceutical companies
facing when they are trying to the implement their CSR initiatives. Although
such established firms are usually supposed to put aside some of their profits
for CSR projects, the abundance of financial flows may not be enough, especially
for these companies with smaller capital or operating in harsh market
environments. Also, human resources and expertise towards CSR planning,
implementation, and monitoring presupposes triage and fiscal responsibility
ready to be expended. It may appear as a strain to organizational capacities,
especially, companies with trimmed operating structure.
However,
instituting the measurement and evaluation for societal value creation by the
pharmaceutical corporates is the ensuing stage. unlike purely financial indices
as those are revenue and profit, the social, the environmental and the economic
impact of CSR requires complex and sophisticated monitoring and evaluation
programs, advanced data collection means, and accurate and sophisticated
engines of assessment. Social impact that is intangible and requires a longer
time horizon to measure the outcome is tremendously complicated to be depicted
as tangible results, which may not be appropriately communicated to the
stakeholders and highlight the value of their CSR work.
At the same
time, among the daunting tasks of managing a uniform view on CSR means and
actions across pharmaceutical worldwide entities and business divisions in a
multinational operating pharmaceutical company is the issue of various
requirements and regulations. Adjusting CSR strategies on the local scale,
being culturally sensitive, and obeying laws and regulations beside avoiding to
deviate from global CSR objectives at the same time requires strategic
coordination, standardized processes, and effective communication and
connections.
The
pharmaceutical industry is wrestled multitude of challenges in the process of
realizing the CSR philosophy, ranging from the balancing of company's
commercial interests with social good on one hand to the regulatory complexities
on the other; effective stakeholders' management issues; additional challenges
brought by a resource constraint; the impossibility of accurate measuring
impact; and, finally, the harmonization of the CSR implementation across
various geographies and Solving these problems demands of proactive, strategic
planning, stakeholder participation as well as innovation, and determination
concerning longevity and responsible corporate citizenship concept. In spite of
the difficulties, as pharmaceutical companies occur to play a central role of
incorporate CSR standards and performing good social and environmental results,
it brings about more equitable and sustainable development.
CONCLUSION-
In
conclusion, The Companies Act, 2013[43],
has proved to be a game changer for the industry in that it has sought to
formalize CSR responsibilities for the eligible entities including
pharmaceutical companies via obligating them to allocate resources to socially
useful programs. Nevertheless, amongst the various quandaries that largely
commercial enterprises have to confront on a daily basis; striking a balance
between commercial interests and public interests endeavour, navigating through
regulatory minefields, engaging stakeholder groups appropriately, managing
resource limitations, monitoring the form and extent of impact attainment, and
harmonizing the alignment between the various business units and geographies
need to strictly be adhered to in compliance with CSR provisions. By creating
CSR committees, producing strategic plans, reaching out to the stakeholders,
and providing transparent reports, these companies have manifestly shown that
they are really in favour of responsible corporate citizenship and sustainable
development. Besides that, pharmaceutical companies which are operating in that
country bear a lot of responsibility to the community and the greater society
of that country through charitable work in liaison with the society by giving
examples such as medical outreach, educational participation, environmental
conservation, and people economic empowerment. Besides fulfilling their
legal responsibilities, in addition, they use a perfect way of incorporating
CSR within their business activities and operations. This innovation being
a breakthrough in company image is very crucial as increased trust and shared
value is taking place among stakeholders. What this way means, is that the
overall work acceptance is surpassing with the effective regulations. Though
the activities mentioned above largely cater to the social challenges and
innovations in CSR, efforts will be paramount to maximize the contribution of
private sector to good society. Succeeding implementation of meaningful
strategies for impact measurement and strengthening inter organisational
partnerships with the stakeholders will be key factors towards drug companies’
CSR drive. By implementing proper CSR initiatives pharmaceutical companies can
revolutionise the healthcare sector and promote social justice and
sustainability as a whole.
RECOMMENDATION-
The Indian
pharmaceutical industry has its own challenges and setbacks to face in
implementing Corporate Social responsibility guidelines and rules. The research
paper focused on various problems faced by the sector and some recommendations
which can make compliance with CSR guidelines smoother.
A
sustainable system of innovation is integral in this day and world which can
make the access to healthcare accessible to all. The Indian pharma can focus
their CSR measures towards research and development of life saving and low cost
medicines, which can in turn help the society. They can further collaborate
with the government, or NGOs supporting this cause. This way they can get a
value for their money and also comply with the CSR guidelines.
One major
barrier in implementation of CSR policies is lack of transparency and
accountability. The pharmaceutical sector can take an initiative to regularly
disclosing their CSR activities and proper utilisation of funds. Adopting
stakeholder engagement procedures can also help to assure conformity with
society norms and expectations and improve credibility.
Indian
pharmaceutical companies such as Dr. Reddy’s Laboratories and Sun
Pharmaceutical Industries Limited have taken great initiatives in complying
with CSR guidelines and uplifting the society. For instance, in complying with
the CSR guidelines, Dr. Reddy’s Laboratories has focused on healthcare programs
through unique initiatives like mobile health clinics and telemedicine. And Sun
Pharmaceutical Industries Limited has focused on making healthcare accessible
to the impoverished section of the society.
Pharmaceutical
industries have the resources—money, people, experience, and strategic
thinking—to support significant societal change. They have productive
collaborations with non-governmental organisations, and the government intends
to accelerate India's social development in a positive direction. The majority
of businesses saw corporate social responsibility (CSR) as a "expense"
rather than as a means of improving the value of their company, partnering with
the community, and helping the environment. Through such initiatives they can
bring a change in the society.
[1] Companies Act, 2013.
(2013). India.
[2] Companies Act, 2013, § 135.
[3] Companies Act, 2013, § 135.
[4] Companies Act, 2013.
(2013). India.
[5] Companies Act, 2013, § 135.
[6] Companies (Corporate Social
Responsibility Policy) Rules, 2014. (2014). India.
[7] Companies Act, 2013.
(2013). India.
[9] Companies Act, 2013.
(2013). India.
[10]Dahlsrud, A. (2008). How corporate social
responsibility is defined: An analysis of 37 definitions. Corporate Social
Responsibility and Environmental Management, 15 (1), 1-13.
https://doi.org/10.1002/csr.132
[11]Carroll, A. B. (1991). The pyramid of
corporate social responsibility: Toward the moral management of organizational
stakeholders. Business Horizons, 34(4), 39-48.
https://doi.org/10.1016/0007-6813(91)90005-G
[12]Batra,
N. (2019). Corporate social responsibility under companies act, 2013: An
overview. International Journal of Legal Insights, 4(1), 105-112.
[13]Chopra,
A., & Marriya, A. (2018). Corporate social responsibility and its
implementation in India. SJCC Management Research Review, 5(2),
7-15.
[14]Jain,
A., & Vashisht, A. (2017). Corporate social responsibility in India:
Evolution, challenges, and strategies for sustainability. International
Journal of Indian Culture and Business Management, 2(3), 274-291.
https://doi.org/10.1504/IJICBM.2017.085298
[15] Sharma, A., & Khanna, P.
(2014). Corporate social responsibility in India: An exploration of Indian
pharmaceutical companies. Asian Journal of Business Ethics, 3(2), 171-184.
https://doi.org/10.1007/s13520-014-0036-3
[16] Mishra, S., & Suar, D. (2010).
Do stakeholders' corporate social responsibility orientation matter? Evidence
from India. Global Business Review, 11(2), 199-214.
https://doi.org/10.1177/097215091001100205
[17] Bhatia, A., & Tuli, S. (2017).
Corporate social responsibility and financial performance: A study of Indian
companies. Paradigm, 21(2), 177-190. https://doi.org/10.1177/0971890717738160
[18]Hildebrand, D., DeMotta, Y., Sen, S., &
Valenzuela, A. (2017, April 22). Consumer Responses to Corporate Social
Responsibility (CSR) Contribution Type. Journal of Consumer Psychology.
https://doi.org/10.1093/jcr/ucx063
[19]Hutchinson, R., Novacek, G., Chin, V., & Falco, G.
(2023, May 25). Socially Transformative Business Is Smart Business. BCG Global.
https://www.bcg.com/publications/2023/socially-transformative-business-is-smart-business
[23]Companies (Corporate Social
Responsibility Policy) Rules, 2014. (2014). India. Rule 2(1)(d).
[25]Companies (Corporate Social
Responsibility Policy) Rules, 2014. (2014). India. Rule 2.
[27]Companies (Corporate Social
Responsibility Policy) Rules, 2014. (2014). India. Rule 7.
[34] Novartis AG v. Union of India
& Ors. (2013). 6 SCC 1
[35] Bayer Corporation v. Union of
India (2014). 59 PTC 1 (Del) [DB]
[36] Union of India v. Pfizer
Limited (2017) AIR 2018 Supreme Court 265
[37] Companies Act, 2013.
(2013). India.
[38] Companies Act, 2013.
(2013). India.
[39] Companies Act, 2013,
schedule VII.
[40] Companies Act, 2013.
(2013). India.
[41] Companies Act, 2013.
(2013). India.
[43] Companies Act, 2013.
(2013). India.
Article Information
CORPORATE SOCIAL RESPONSIBILITY IN INDIAN PHARMA: COMPLIANCE WITH THE COMPANIES ACT, 2013.
Authors: ANANYA SHARMA, GITARTHI CHANDRA
- Journal IJLRA
- ISSN 2582-6433
- Published 2024/06/17
About Journal
International Journal for Legal Research and Analysis
- Abbreviation IJLRA
- ISSN 2582-6433
- Access Open Access
- License CC 4.0
All research articles published in International Journal for Legal Research and Analysis are open access and available to read, download and share, subject to proper citation of the original work.
Disclaimer: The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of International Journal for Legal Research and Analysis.